The authors reply
- PMID: 41342857
- DOI: 10.1097/CCM.0000000000006924
The authors reply
Conflict of interest statement
Dr. Cioccari’s institution received funding from Fresenius Medical Care, Vantive, CytoSorbents, and Hamilton Medical; he received funding from OrphaSwiss. Dr. Iten has disclosed that he does not have any potential conflicts of interest.
References
-
- Chang K, Guay CS, Johnson-Akeju S, et al.: Biomarkers and delirium in critical care: A field for future investigation author information. Crit Care Med. 2025; 53:e2796–e2797
-
- Iten M, Bachmann K, Jakob SM, et al.: Adjunctive sedation with dexmedetomidine for the prevention of severe inflammation and septic encephalopathy: A pilot randomized controlled study. Crit Care Med. 2025; 53:e1377–e1388
-
- Qu JZ, Mueller A, McKay TB, et al.; MINDDS Study Team: Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): A single-centre, parallel-arm, randomised, placebo-controlled superiority trial. EClinicalMedicine. 2023; 56:101796
-
- Janigro D, Mondello S, Posti JP, et al.: GFAP and S100B: What you always wanted to know and never dared to ask. Front Neurol. 2022; 13:835597
LinkOut - more resources
Full Text Sources
